Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...
Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.
Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...
Switzerland: A recent study published in JAMA Neurology has highlighted key factors influencing the recurrence of ...
PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...
Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...
Sandra Kuzmecka (13) from Glenkeen Park, Fairgreen, Portlaoise, Co Laois, died at Children’s Health Ireland at Temple Street ...
On a much more serious note, March is awareness month for conditions such as multiple sclerosis, bleeding disorders, kidneys, traumatic brain injuries, developmental disabilities, cerebral palsy, ...
Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...
The incidence rate of pulmonary embolism-related hospitalizations in pediatric patients revealed that this outcome occurred ...
Endovascular thrombectomy does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.